/
CBIA
$0.00+$0.00 (+0.00%)prev close
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.00 – $0.00
0% from low
Exchange
OTC Link
CS
Borrow rate
0.25%
Easy to borrow
Price (6 mo)
Loading chart…
Change$-0.13
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2012 | 2013 | 2021 | 2022 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Cost of revenue | $9.9K | $9.9K | $0 | $0 |
| Gross profit | −$9.9K | −$9.9K | $0 | $0 |
| Gross margin | — | — | — | — |
| R&D | $42.0K | $413.6K | $0 | $0 |
| Operating income | −$118.4K | −$510.2K | −$1.8K | −$764.6K |
| EBITDA | −$108.6K | −$108.6K | −$1.8K | −$764.6K |
| Net income | −$525.9K | −$850.9K | −$1.8K | −$764.7K |
| Net margin | — | — | — | — |
| EPS (diluted) | -0.02 | -0.02 | 0.00 | -0.01 |
Annual figures · source: Financial Modeling Prep
Peer comparison
CANOPUS BIOPHARMA INC
CANOPUS BIOPHARMA INC
Held by traders on TradeandTell
No one on the platform currently holds CBIA.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in CBIA as of their last filing.
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded CBIA yet.
